Post

Reprocessor Identification Requirements for Reprocessed Single-Use Devices

This guidance outlines the requirements for manufacturers who reprocess single-use devices (SUDs) to prominently and conspicuously mark their devices with their identification. It specifically implements Section 301 of the Medical Device User Fee and Modernization Act of 2002, as amended by the Medical Device User Fee Stabilization Act of 2005.

  1. Assess current labeling practices for reprocessed SUDs
  2. Develop a marking strategy based on device characteristics and available space
  3. Implement appropriate marking method (direct marking, attachment, or detachable label)
  4. Ensure marking meets prominence and conspicuousness criteria
  5. Update quality system procedures to include new labeling requirements
  6. Train relevant personnel on new labeling requirements
  7. Implement by the applicable deadline
  8. For detachable labels, include instructions for healthcare providers to affix the label to patient records
  9. Document compliance with marking requirements in device master records

Key Considerations

Labelling

  • The reprocessor’s mark must be prominent and conspicuous on the device or attachment
  • Key factors for prominent and conspicuous marking:
    • Available space on the device
    • Contrast between mark and background
    • Font or graphic readability
    • Meaning and understandability of the mark
  • A detachable label on packaging can be used if the original device doesn’t prominently display the OEM’s mark
  • The detachable label must be designed to be affixed to patient medical records

Other considerations


Original guidance

  • Reprocessor Identification Requirements for Reprocessed Single-Use Devices
  • HTML / PDF
  • Issue date: 2006-05-01
  • Last changed date: 2020-02-28
  • Status: FINAL
  • Official FDA topics: Medical Devices, Labeling, Postmarket, User Fees
  • ReguVirta summary file ID: ae0edbb8f9c188a01315b7481caa9c9a
This post is licensed under CC BY 4.0 by the author.